New Crystal Drug Protects Transplanted Cells Without Immune Suppression for One Year
Breakthrough crystal technology enables transplanted insulin-producing cells to survive and function for a full year without traditional immunosuppression.
348 articles in this topic
Breakthrough crystal technology enables transplanted insulin-producing cells to survive and function for a full year without traditional immunosuppression.
Scientists develop first drug targeting AVIL protein, showing effectiveness against deadly glioblastoma tumors in preclinical trials.
Small trial tests autologous bronchial stem cells to repair damaged lung tissue in chronic obstructive pulmonary disease patients.
Scientists created muscle organoids from patient cells that show gene therapy improves muscle function but fails to stop harmful scarring.
New research reveals how stretching forces activate stem cells and immune cells to rebuild facial bone structure through collagen remodeling.
New research reveals how high blood sugar directly impairs muscle stem cells, leading to weaker muscles and poor injury recovery.
Scientists discover how to reverse scarring that prevents clear vision recovery after corneal damage.
New tissue-engineered heart conduit could restore normal circulation in children with congenital heart defects, potentially extending lifespans.
New research identifies a drug target that could help millions of fractures heal properly when blood flow is compromised.
Enhanced stem cells reduced inflammation and improved bladder function in rats with nerve damage.
Researchers demonstrate that transplanting healthy lung cells can repair damaged lungs in mice with genetic disease.
New research reveals tissue-specific barriers to AAV9 gene therapy effectiveness, particularly in liver cells of primates.